We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 389

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada, USA
  • -
  • May 22 2013

The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 13 2013

This case involved a dispute over ownership and alleged infringement of copyright in a number of computer software programs. The Court held that the

Teva Canada Innovation v. Attorney General of Canada

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 8 2013

The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an

Reynolds Presto Products Inc. v. P.R.S. Mediterranean Ltd., 2013 FCA 119

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 8 2013

The Court of Appeal has overturned a lower court decision and struck the mark NEOWEB from the register because it is confusing with the earlier

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 8 2013

The governments of a number of provinces sought judicial review of a decision of the Copyright Board of Canada dismissing their objection that the

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 1 2013

The Court granted a Prohibition Order to AstraZeneca, preventing Ranbaxy from entering the market with a generic version of ompeprazole until the

NOC proceedings

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 25 2013

The Federal Court found Teva’s allegations of invalidity were not justified for Novartis’ narrow compound patent, while the allegations against

Other cases of interest

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 25 2013

As mentioned last week, two IP leave decisions were released last Thursday. Neither appeal obtained leave. The first, Gilead Science Canada Inc. v

Appeal granted with respect to summary judgment re standing to sue for infringement

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 18 2013

Nautical Data International v. C-Map USA The Court granted a motion for summary judgment relating to standing to sue for copyright infringement in

Decisions in leave to appeal to the Supreme Court

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • March 18 2013

The Supreme Court is releasing their judgment for two leave decisions this Thursday. The first, Gilead Science Canada Inc. v. Minister of Health

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy